Skip to main content
. 2017 Feb 28;84(2):220–226. doi: 10.1016/j.bjorl.2017.02.002

Table 3.

Summary of effect of BMI on head and neck cancer patients.

Authors, Years BMI categories Treatment modality Effect of BMI
Takenaka et al.,15 2015 Obese or overweight (25 kg/m2), normal (18.5 kg/m2 and <25 kg/m2), and underweight (<18.5 kg/m2). Surgery, CRT, RT 192 surgically treated patients no statistically significant the effect of BMI on overall survival.
In other treatment modalities high BMI was associated with a better prognosis.
Huang PY et al.,17 2013 Obese (27.5 kg/m2), overweight (23.0–27.4 kg/m2), normal weight (18.5–22.9 kg/m2), underweight (<18.5 kg/m2). IC + CCRT Higher BMI was associated with increased failure free survival and overall survival.
IC + RT No influence on the risk of locoregional recurrences.
Lin YH et al.,18 2015 Two groups (<23 kg/m2 vs. ≥23 kg/m2) IMRT, CCRT, RT/CCRT + IC BMI was not significantly associated with overall survival, disease specific survival, distant metastasis free survival, or locoregional free survival.
van Bokhorst–de van der Schuer B. et al.,21 1999 BMI not calculated, Percentage of weight loss during the 6 months before treatment, the percentage of ideal body weight, serum albumin, total lymphocyte count, nutritional index, and bioelectrical impedance analysis. Surgery None of the studied nutritional parameters were associated with survival.
Present study Morbid obese (>40 kg/m2), obese (31–40 kg/m2), overweight (26–30 kg/m2), normal weight (18.5–25 kg/m2), underweight (<18.5 kg/m2). Surgery BMI was not significantly associated with overall survival, disease free survival

CRT, chemoradiation therapy; RT, radiation therapy; CCRT, concurrent CRT; BMI, body mass index; IC, induction chemotherapy; IMRT, intensity-modulated radiotherapy.